Journal Home > Volume 10 , Issue 1

Theories proposing a role of specific dietary components or food supplements in the prevention or treatment of COVID-19 have received extensive social media coverage.

A multitude of scientific publications have also pointed to the importance of food and nutrition in combating the COVID-19 pandemic. The present perspective critically addresses the question of what food science can actually contribute in this context.

Animal studies suggest that micronutrients, food bioactives or functional foods may carry the potential to augment viral defense. However, the specific roles of food components in viral infectious diseases in humans remain unclear. Rigorous research assessing the efficacy of food compounds in counteracting infections would require long-term randomized controlled trials in large samples. While no foods, single nutrients or dietary supplements are capable of preventing infection with COVID-19, a balanced diet containing sufficient amounts of macronutrients and diverse micronutrients is a prerequisite of an optimally functioning immune system. High-energy diets and obesity are major risk factors for a more severe course of COVID-19.

Therefore, population-wide body weight control and weight reduction in overweight people are important preventive measures. Diet may play a beneficial role in maintaining a healthy body weight and preventing non-communicable conditions.


menu
Abstract
Full text
Outline
About this article

Food science and COVID-19

Show Author's information Klaus W. Lange( )
Department of Experimental Psychology, University of Regensburg, Regensburg, Germany

Peer review under responsibility of KeAi Communications Co., Ltd.

Abstract

Theories proposing a role of specific dietary components or food supplements in the prevention or treatment of COVID-19 have received extensive social media coverage.

A multitude of scientific publications have also pointed to the importance of food and nutrition in combating the COVID-19 pandemic. The present perspective critically addresses the question of what food science can actually contribute in this context.

Animal studies suggest that micronutrients, food bioactives or functional foods may carry the potential to augment viral defense. However, the specific roles of food components in viral infectious diseases in humans remain unclear. Rigorous research assessing the efficacy of food compounds in counteracting infections would require long-term randomized controlled trials in large samples. While no foods, single nutrients or dietary supplements are capable of preventing infection with COVID-19, a balanced diet containing sufficient amounts of macronutrients and diverse micronutrients is a prerequisite of an optimally functioning immune system. High-energy diets and obesity are major risk factors for a more severe course of COVID-19.

Therefore, population-wide body weight control and weight reduction in overweight people are important preventive measures. Diet may play a beneficial role in maintaining a healthy body weight and preventing non-communicable conditions.

Keywords: COVID-19, Obesity, Food science, Micronutrients, Functional foods

References(68)

[1]

N. Zhu, D. Zhang, W. Wang, et al., A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med. 382 (2020) 727–733, http://dx.doi.org/10.1056/NEJMoa2001017.

[2]
WHO, Rolling Updates on Coronavirus Disease (COVID-19): WHOCharacterizes COVID-19 As a Pandemic, Available at: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/events-as-they-happen.Accessed March 30, 2020.
[3]

K.W. Lange, The prevention of COVID-19 and the need for reliable data, Mov. Nutr. Health Dis. 4 (2020) 53–63.

[4]

K.W. Lange, Movement and nutrition in health and disease, Mov. Nutr. Health Dis. 4 (2017) 1–2, http://dx.doi.org/10.5283/mnhd.9.

[5]
R.R. Watson (Ed.), Nutrition, Disease Resistance, and Immune Function, Marcel Dekker, New York, 1984.
[6]

R.K. Chandra, Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14304–14307, http://dx.doi.org/10.1073/pnas.93.25.14304.

[7]

R. Valdés-Ramos, B.E. Martínez-Carrillo, I.I. Aranda-González, et al., Diet, exercise and gut mucosal immunity, Proc. Nutr. Soc. 69 (2010) 644–650, http://dx.doi.org/10.1017/S0029665110002533.

[8]

T.P. Wypych, B.J. Marsland, N.D. Ubags, The impact of diet on immunity and respiratory diseases, Ann. Am. Thorac. Soc. 14 (2017) S339–S347, http://dx.doi.org/10.1513/AnnalsATS.201703-255AW.

[9]

K. Norman, C. Pichard, H. Lochs, et al., Prognostic impact of disease-related malnutrition, Clin. Nutr. 27 (2008) 5–15, http://dx.doi.org/10.1016/j.clnu.2007.10.007.

[10]

P. Schuetz, R. Fehr, V. Baechli, et al., Individualised nutritional support in medical inpatients at nutritional risk: a randomized clinical trial, Lancet 393 (2019) 2312–2321, http://dx.doi.org/10.1016/S0140-6736(18)32776-4.

[11]

R. Caccialanza, A. Laviano, F. Lobascio, et al., Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol, Nutrition 74 (2020) 110835, http://dx.doi.org/10.1016/j.nut.2020.110835.

[12]

F. Yang, Y. Zhang, A. Tariq, et al., Food as medicine: a possible preventive measure against coronavirus disease (COVID-19), Phytother. Res. 34 (2020) 1–13, http://dx.doi.org/10.1002/ptr.6770.

[13]

N. Yahfoufi, N. Alsadi, M. Jambi, et al., The immunomodulatory and anti-Inflammatory role of polyphenols, Nutrients 10 (2018) 1618, http://dx.doi.org/10.3390/nu10111618.

[14]

W. Li, M.J. Moore, N. Vasilieva, et al., Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature 426 (2003) 450–454, http://dx.doi.org/10.1038/nature02145.

[15]

K. Kuba, Y. Imai, S. Rao, et al., A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat. Med. 11 (2005) 875–879, http://dx.doi.org/10.1038/nm1267.

[16]

M. Gheblawi, K. Wang, A. Viveiros, et al., Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the reninangiotensin system, Circ. Res. 126 (2020) 1456–1474, http://dx.doi.org/10.1161/CIRCRESAHA.120.317015.

[17]

R. Yan, Y. Zhang, Y. Li, et al., Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science 367 (2020) 1444–1448, http://dx.doi.org/10.1126/science.abb2762.

[18]

B.P. Chew, J.S. Park, Carotenoid action on the immune response, J. Nutr. 134 (2004) 257S–261S, http://dx.doi.org/10.1093/jn/134.1.257S.

[19]

M. Burkard, C. Leischner, U.M. Lauer, et al., Dietary flavonoids and modulation of natural killer cell implications in cancer and viral diseases, J. Nutr. Biochem. 46 (2017) 1–12, http://dx.doi.org/10.1016/j.jnutbio.2017.01.006.

[20]

R. Frei, M. Akdis, L. O'Mahony, Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence, Curr. Opin. Gastroenterol. 31 (2015) 153–158, http://dx.doi.org/10.1097/MOG.0000000000000151.

[21]

C. Maldonado Galdeano, S.I. Cazorla, J.M. Lemme Dumit, et al., Beneficial effects of probiotic consumption on the immune system, Ann. Nutr. Metab. 74 (2019) 115–124, http://dx.doi.org/10.1159/000496426.

[22]

E.J. Kang, S.J. Kim, I.H. Hwang, et al., The effect of probiotics on prevention of common cold: a meta-analysis of randomized controlled trial studies, Korean J. Fam. Med. 34 (2013) 2–10.

[23]

Q. Hao, B.R. Dong, T. Wu, Probiotics for preventing acute upper respiratory tract infections, Cochrane Database Syst. Rev. 2015 (2015), CD006895, http://dx.doi.org/10.1002/14651858.CD006895.pub2.

[24]

S. King, J. Glanville, M.E. Sanders, et al., Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis, Br. J. Nutr. 112 (2014) 41–54, http://dx.doi.org/10.1017/S0007114514000075.

[25]

H.Y. Jin, L. Cai, C. Z. S, et al., A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia, Mil. Med. Res. 7 (2020) 4, http://dx.doi.org/10.1186/s40779-020-0233-6.

[26]

K. Xu, H. Cai, Y. Shen, et al., Management of corona virus disease-19 (COVID-19): the Zhejiang experience, Zhejiang Da Xue Xue Bao Yi Xue Ban 49 (2020) 147–157.

[27]

J.W.Y. Mak, F.K.L. Chan, S.C. Ng, Probiotics and COVID-19: one size does not fit all, Lancet Gastroenterol. Hepatol. 5 (2020) 644–645, http://dx.doi.org/10. 1016/S2468-1253(20)30122-9.

[28]

E.S. Wintergerst, S. Maggini, D.H. Hornig, Contribution of selected vitamins and trace elements to immune function, Ann. Nutr. Metab. 51 (2007) 301–323, http://dx.doi.org/10.1017/S0029665108006939.

[29]

R. Jayawardena, P. Sooriyaarachchi, M. Chourdakis, et al., Enhancing immunity in viral infections, with special emphasis on COVID-19: a review, Diabetes Metab. Syndr. 14 (2020) 367–382, http://dx.doi.org/10.1016/j.dsx. 2020.04.015.

[30]

R. Bouillon, C. Marcocci, G. Carmeliet, et al., Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions, Endocr. Rev. 40 (2019) 1109–1151, http://dx.doi.org/10.1210/er.2018-00126.

[31]

A.R. Martineau, D.A. Jolliffe, R.L. Hooper, et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ 356 (2017) i6583, http://dx.doi.org/10.1136/bmj.i6583.

[32]

K.W. Lange, Y. Nakamura, Food bioactives, micronutrients, immune function and COVID-19, J. Food Bioact. 10 (2020) 1–8, http://dx.doi.org/10.31665/JFB. 2020.10222.

[33]

P. Yaqoob, Ageing alters the impact of nutrition on immune function, Proc. Nutr. Soc. 76 (2017) 347–351, http://dx.doi.org/10.1017/S0029665116000781.

[34]

M.O. Husson, D. Ley, C. Portal, et al., Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids, J. Infect. 73 (2016) 523–535, http://dx.doi.org/10.1016/j.jinf.2016.10.001.

[35]

K.W. Lange, Y. Nakamura, A. Gosslau, et al., Are there serious adverse effects of omega-3 polyunsaturated fatty acid supplements? J. Food Bioact. 7 (2019) 1–6, http://dx.doi.org/10.31665/JFB.2019.7192.

[36]

C.S. Yang, N. Suh, A.N.T. Kong, Does vitamin E prevent or promote cancer? Cancer Prev. Res. Phila. (Phila) 5 (2012) 701–705, http://dx.doi.org/10.1158/1940-6207.CAPR-12-0045.

[37]

B. Witkop, Paul Ehrlich and his magic bullets – revisited, Proc. Am. Philos. Soc. Held Philadelphia Promot. Useful. Knowl. 143 (2000) 540–557.

[38]

J. Bousquet, J.M. Anto, G. Iaccarino, et al., Is diet partly responsible for differences in COVID-19 death rates between and within countries? Clin. Transl. Allergy 10 (2020) 16, http://dx.doi.org/10.1186/s13601-020-00323-0.

[39]

S.C. Fonseca, I. Rivas, D. Romaguera, et al., Association between consumption of fermented vegetables and COVID-19 mortality at a country level in Europe, BMJ (2020), http://dx.doi.org/10.1101/2020.07.06.20147025.

[40]

A.N. Thorburn, L. Macia, C.R. Mackay, Diet, metabolites, and "western-lifestyle" inflammatory diseases, Immunity 40 (2014) 833–842, http://dx.doi.org/10.1016/j.immuni.2014.05.014.

[41]

S.K. Clinton, J.C. Fleet, H. Loppnow, et al., Interleukin-1 gene expression in rabbit vascular tissue in vivo, Am. J. Pathol. 138 (1991) 1005–1014.

[42]

J.C. Fleet, S.K. Clinton, R.N. Salomon, et al., Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae, J. Nutr. 122 (1992) 294–305, http://dx.doi.org/10.1093/jn/122.2.294.

[43]

A. Christ, P. Günther, M.A.R. Lauterbach, et al., Western diet triggers NLRP3-dependent innate immune reprogramming, Cell 172 (2018) 162–175, http://dx.doi.org/10.1016/j.cell.2017.12.013.

[44]

M.D. van Kerkhove, K.A.H. Vandemaele, V. Shinde, et al., Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis, PLoS Med. 8 (2011), e1001053.

[45]

L.M. Frydrych, G. Bian, D.E. O'Lone, et al., Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality, J. Leukoc. Biol. Suppl. 104 (2018) 525–534, http://dx.doi.org/10.1002/JLB. 5VMR0118-021RR.

[46]

N.V. Dhurandhar, D. Bailey, D. Thomas, Interaction of obesity and infections, Obes. Rev. 16 (2015) 1017–1029, http://dx.doi.org/10.1111/obr.12320.

[47]

N. Finer, S.P. Garnett, J.M. Bruun, COVID-19 and obesity, Clin. Obes. 10 (2020) e12365, http://dx.doi.org/10.1111/cob.12365.

[48]

J. Lighter, M. Phillips, S. Hochman, et al., Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission, Clin. Infect. Dis. 71 (2020) 896–897, http://dx.doi.org/10.1093/cid/ciaa415.

[49]

F. Zhou, T. Yu, R. Du, et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet 395 (2020) 1054–1062, http://dx.doi.org/10.1016/S0140-6736(20)30566-3.

[50]

D.A. Kass, P. Duggal, O. Cingolani, Obesity could shift severe COVID-19 disease to younger ages, Lancet 395 (2020) 1544–1545, http://dx.doi.org/10.1016/S0140-6736(20)31024-2.

[51]

L. Costa Melo, M.A. Mendonç a da Silva, A.C. do Nascimento Calles, Obesity and lung function: a systematic review, Einstein Sao Paulo (Sao Paulo) 12 (2014) 120–125, http://dx.doi.org/10.1590/s1679-45082014rw2691.

[52]

W. Dietz, C. Santos-Burgoa, Obesity and its implications for COVID-19 mortality, Obesity 28 (2020) 1005, http://dx.doi.org/10.1002/oby.22818.

[53]

H. Hauner, Secretory factors from human adipose tissue and their functional role, Proc. Nutr. Soc. 64 (2005) 163–169, http://dx.doi.org/10.1079/pns2005428.

[54]

G. Muscogiuri, G. Pugliese, L. Barrea, et al., Obesity: the "Achilles heel" for COVID-19? Metabolism 108 (2020) 154251, http://dx.doi.org/10.1016/j.metabol.2020.154251.

[55]

M. Eslam, P.N. Newsome, S.K. Sarin, et al., A new definition for metabolic associated fatty liver disease: an international expert consensus statement, J. Hepatol. 73 (2020) 202–209.

[56]

D. Van der Poorten, K.L. Milner, J. Hui, et al., Visceral fat: a key mediator of steatohepatitis in metabolic liver disease, Hepatology 48 (2008) 449–457, http://dx.doi.org/10.1002/hep.22350.

[57]

K.I. Zheng, F. Gao, X.B. Wang, et al., Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease, Metabolism 108 (2020), 154244.

[58]

A. Simonnet, M. Chetboun, J. Poissy, et al., High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation, Obesity 28 (2020) 1195–1199, http://dx.doi.org/10.1002/oby.22831.

[59]

L. Di Renzo, P. Gualtieri, L. Romano, et al., Role of personalized nutrition in chronic-degenerative diseases, Nutrients 11 (2019) 1707, http://dx.doi.org/10.3390/nu11081707.

[60]

K.W. Lange, Mental health problems in COVID-19 and the need for reliable data, Mov. Nutr. Health Dis. 4 (2020) 64–69.

[61]

L. Lei, X. Huang, S. Zhang, et al., Comparison of prevalence and associated factors of anxiety and depression among people affected by versus people unaffected by quarantine during the COVID-19 epidemic in Southwestern China, Med. Sci. Monit. 26 (2020) 1–12.

[62]

J. Qiu, B. Shen, M. Zhao, et al., A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations, Gen. Psychiatry 33 (2020) e100213, http://dx.doi.org/10. 1136/gpsych-2020-100213.

[63]

C.R. Isasi, C.M. Parrinello, M.M. Jung, et al., Psychosocial stress is associated with obesity and diet quality in Hispanic/Latino adults, Ann. Epidemiol. 25 (2015) 84–89, http://dx.doi.org/10.1016/j.annepidem.2014.11.002.

[64]

M.A. Rodríguez, I. Crespo, H. Olmedillas, Exercising in times of COVID-19: what do experts recommend doing within four walls? Rev. Esp. Cardiol. 73 (2020) 527–529, http://dx.doi.org/10.1016/j.rec.2020.04.001.

[65]

K.W. Lange, The international movement and nutrition society and the prevention of disease, Mov. Nutr. Health Dis. 1 (2017) 0.

[66]
P. Walker, No 10 Plans Weight Loss Drive to Ready UK for Expected COVID-19Second Wave, Guardian, July 11, 2020. Available at: https://www.theguardian.com/society/2020/jul/11/no-10-plans-weight-loss-drive-toready-uk-for-expected-covid-19-second-wave. Accessed July 17, 2020.
[67]
Public Health England, Major New Campaign Encourages Millions to LoseWeight and Cut COVID-19 Risk, Available at: https://www.gov.uk/government/news/major-new-campaign-encourages-millions-to-loseweight-and-cut-covid-19-risk. Accessed July 28, 2020.
[68]

D.K. Chu, E.A. Akl, S. Duda, et al., Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis, Lancet 395 (2020) 1973–1987, http://dx.doi.org/10.1016/S0140-6736(20)31142-9.

Publication history
Copyright
Rights and permissions

Publication history

Received: 17 August 2020
Accepted: 20 August 2020
Published: 23 September 2020
Issue date: January 2021

Copyright

© 2021 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return